Fresh analysis indicates that individuals who stop using new GLP-1 drugs like semaglutide or tirzepatide tend to recover lost weight far faster than those who halt conventional diet and exercise regimens.
Published data in a leading medical journal points out that while overweight individuals frequently drop about a fifth of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Users buying these medications must be aware of the potential of rapid weight regain when the treatment ends," stated expert Dr. Susan Jebb.
Such speed of recovery implies a return to starting weight within about a year and a half.
Analyzing Therapies
The study, which examined dozens of trials involving over 9,000 of participants, contrasted the results of these new drugs with older methods.
Researchers emphasize that people who lose weight through lifestyle changes alone typically experience a more gradual creep back—approximately 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Doctors suggest the way of the injections accounts for the accelerated regain.
These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the body to produce less of its own natural hormone, and may also lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' leads to appetite is unsuppressed, making excessive eating much more probable."
A Lifelong Disease?
Medical guidelines advise the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
Many experts contend that, considering the high risk of relapse, the treatment might need to be ongoing.
This perspective is supported by pharmaceutical companies, who note that the results "emphasize the long-term nature of obesity," akin to managing conditions like diabetes.
Patient Experiences
People who have discontinued the medication describe a powerful return of hunger.
"It was like something activating and you become extremely hungry," recalled a patient.
The struggle is exacerbated if users have not adopted sustainable lifestyle or habit modifications during treatment.
Growing Adoption
Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Use is greater among females compared to males.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than public health services.
Finally, researchers stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone solution and long-term success hinges on combined lifestyle changes.
